AstraZeneca on Tuesday revealed that it’s adding $2 billion more to its current outlay in the U.S., representing a total ...

After a protracted rough patch—which has included layoffs, partnership terminations and lawsuits—San Francisco’s Nektar ...

Generic drugmaker Accord Healthcare has announced a £50 million ($65 million) investment in the UK that will include the ...

AptarGroup Inc, a firm involved in drug and consumer product dosing, dispensing and protection technologies, held the ...

A key reason positions haven't been filled is that they require travel that ranges from 25% to 75% of the time.

The factory was manufacturing the suspected culprit ... help them determine the cause of the deaths. Kobayashi Pharmaceutical also has a plant in Wakayama Prefecture where the benikoji ingredient ...

Additionally, in East Port Said Industrial Zone, Gennvax Egypt operates a $150 million vaccine manufacturing plant over a 49,000 sqm area, and International Drug Agency for Pharmaceutical Industry ...

When Hurricane Helene damaged western North Carolina in September, filling medical facilities with people who couldn't be ...

The government’s deal with Maryland-based Novavax requires the company to obtain regulatory approval for a vaccine using ingredients made at the Biologics Manufacturing Centre (BMC) in Montreal before ...

The company is establishing a North Carolina factory for cold medicine as postpandemic pharma demand has grown more ...

The Food Processing sector continues to attract significant investment, with several projects from companies such as ...